AR025008A1 - Derivados del pirido(1-2-a)benzimidazol sustituidos en el carbono 6 del anillo, utiles en el tratamiento de trastornos del sistema nervioso central - Google Patents

Derivados del pirido(1-2-a)benzimidazol sustituidos en el carbono 6 del anillo, utiles en el tratamiento de trastornos del sistema nervioso central

Info

Publication number
AR025008A1
AR025008A1 ARP000103971A ARP000103971A AR025008A1 AR 025008 A1 AR025008 A1 AR 025008A1 AR P000103971 A ARP000103971 A AR P000103971A AR P000103971 A ARP000103971 A AR P000103971A AR 025008 A1 AR025008 A1 AR 025008A1
Authority
AR
Argentina
Prior art keywords
disorders
useful
carbon
treatment
ring
Prior art date
Application number
ARP000103971A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR025008A1 publication Critical patent/AR025008A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un derivado de pirido[1,2- a]benzimidazol sustituido en el carbono 6 del anillo, de formula (1) se describen métodos de preparacion y composicionesfarmacéuticas que contienen el derivado sustituido de pirido[1,2-a]benzimidazol como principio activo.Los derivados sustituidos de pirido[1,2-a]benzimidazolson utiles en el tratamiento de trastornos del sistema nervioso central.
ARP000103971A 1999-08-02 2000-08-01 Derivados del pirido(1-2-a)benzimidazol sustituidos en el carbono 6 del anillo, utiles en el tratamiento de trastornos del sistema nervioso central AR025008A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14673199P 1999-08-02 1999-08-02

Publications (1)

Publication Number Publication Date
AR025008A1 true AR025008A1 (es) 2002-11-06

Family

ID=22518751

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103971A AR025008A1 (es) 1999-08-02 2000-08-01 Derivados del pirido(1-2-a)benzimidazol sustituidos en el carbono 6 del anillo, utiles en el tratamiento de trastornos del sistema nervioso central

Country Status (12)

Country Link
US (1) US6358946B1 (es)
EP (1) EP1200433B1 (es)
JP (1) JP2003506373A (es)
AR (1) AR025008A1 (es)
AT (1) ATE321044T1 (es)
AU (1) AU779686B2 (es)
CA (1) CA2391766A1 (es)
DE (1) DE60026848T2 (es)
ES (1) ES2260034T3 (es)
MX (1) MXPA02001308A (es)
TW (1) TWI261590B (es)
WO (1) WO2001009132A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL403149A1 (pl) 2013-03-14 2014-09-15 Celon Pharma Spółka Akcyjna Nowe związki pochodne pirazolilobenzo[d]imidazolu

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221369B1 (en) * 1992-08-19 2002-09-28 Mcneilab Inc 3-oxo-pyrido(1,2-a)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a)-benzimidazole-5-carboxyl derivatives, their preparation pharmaceutical compositions suitable for treating central nervous system disorders containing thereof and their preparation
US5521200A (en) 1993-12-30 1996-05-28 Ho; Winston 2-oxo-pyrrolo[1,2-A]benzimidazole-3-carboxyl derivatives useful in treating central nervous system disorders
NZ335060A (en) * 1996-10-07 2000-05-26 Ortho Mcneil Pharm Inc 5-heteroatom containing alkyl substituted-3-oxo-pyrido[1,2-a]benzimidazole-4-carboxamide derivatives and medicaments useful in treating central nervous system disorders
US5922731A (en) 1997-06-30 1999-07-13 Ortho Pharmaceutical Corporation 5- (heteroaryl)alkyl!-3-oxo-pyrido 1,2-a!benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders
ES2221996T3 (es) * 1997-10-07 2005-01-16 Ortho-Mcneil Pharmaceutical, Inc. Derivados de dipirido-imidazol utiles para el tratamiento de trastornos del sistema nervioso central.
WO1999040092A1 (en) 1998-02-04 1999-08-12 Neurogen Corporation Oxo-dipyridoimidazole-carboxamides: gaba brain receptor ligands
EP1107966B1 (en) 1998-08-25 2005-07-27 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands

Also Published As

Publication number Publication date
AU6228900A (en) 2001-02-19
JP2003506373A (ja) 2003-02-18
MXPA02001308A (es) 2004-07-16
ATE321044T1 (de) 2006-04-15
ES2260034T3 (es) 2006-11-01
EP1200433B1 (en) 2006-03-22
CA2391766A1 (en) 2001-02-08
DE60026848T2 (de) 2006-11-16
US6358946B1 (en) 2002-03-19
TWI261590B (en) 2006-09-11
DE60026848D1 (de) 2006-05-11
EP1200433A1 (en) 2002-05-02
WO2001009132A1 (en) 2001-02-08
AU779686B2 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
ES2132223T3 (es) Derivados de indol condensados en calidad de antagonistas del receptor 5-ht4.
AR025959A1 (es) DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
UY24560A1 (es) Derivados arilos de la pirimidina útiles como antagonistas 5ht2b selectivos
AR022860A1 (es) Derivados de camptotecina que poseen actividad antitumoral
CN115916215A (zh) 迷幻剂衍生物的经皮微剂量递送
AR033367A1 (es) Derivados de imidazopirimidina y derivados de triazolopirimidina, un procedimiento para su preparacion, medicamentos, una composicion farmaceutica, y uso de dichos derivados para la preparacion de medicamentos
CR20110095A (es) Derivados biciclicos [3.1.0] como inhibidores del transportador de glicina (divisional solicitud 8333)
ES2191192T3 (es) Tienopirimidinas.
UY28510A1 (es) Compuestos quimicos
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
UY27457A1 (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
AR023346A1 (es) Compuestos derivados biciclicos substituidos utiles como agentes contra el cancer, uso de los mismos para preparar un medicamento, composicionesfarmaceuticas y procedimiento de preparacion de los compuestos
MX9307940A (es) Nuevos derivados de la imidazopiridina, proceso para su preparacion y formulaciones farmaceuticas que los incluyen
PA8496301A1 (es) Inhibidores de metaloproteasas.
WO2003013484A3 (en) N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
ATE247115T1 (de) Substituierte stickstoff-heterocyclische derivate und deren pharmazeutische verwendung
ECSP045139A (es) DERIVADOS DE ACETILENO QUE TIENEN ACTIVIDAD ANTAGONISTICA DE MGluR5
PA8593101A1 (es) Composiciones para el tratamiento de crecimiento celular anormal
UY28536A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
UY28356A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos
ES2175386T3 (es) Derivados de 2,3-benzodiazepina y su utilizacion como inhibidores de receptores de ampa.
PA8458301A1 (es) 2-aminopiridinas con sustituyentes alcoxi ramificados
ES2171911T3 (es) Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos.
AR038620A1 (es) Derivados de 1-(alquil), 1-((heteroaril)alquil) y 1-((aril) alquil)-7-(pirimidin-4-il)-imidazo(1,2-a)pirimidin-5(1h)-ona
AR005102A1 (es) Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento.

Legal Events

Date Code Title Description
FB Suspension of granting procedure